drugset / Trial / NCT00657241

Cardioprotective Benefits of Carvedilol-CR or Valsartan Added to Lisinopril

NCT00657241

RandomizedCrossoverSingle-blindTreatment

Summary

14-week single blind, double baseline, forced-titration, cross-over comparison of the cardiac benefits of Coreg CR compared to valsartan added to existing ACE inhibition

Timeline

Start
2008-04
Primary completion
2010-04
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carvedilol Other / unclassified 40 mg
Comparator Valsartan Small molecule 320 mg

Indications